The $2,000 Medicare Drug Cost Cap | What Changes in 2026
The Inflation Reduction Act restructures Medicare Part D to cap annual out-of-pocket drug spending at $2,000. For millions of seniors on expensive medications, this is the most significant prescription drug reform in two decades.
What Changed
The IRA transforms Part D's benefit phases. Three structural changes eliminate the most punishing cost traps that seniors have faced for years.
| Part D Feature | Before 2026 | Starting 2026 |
|---|---|---|
| Coverage Gap ("Donut Hole") | 25% coinsurance on brand-name drugs Beneficiaries paid thousands in the gap phase |
Eliminated entirely No more gap phase in benefit structure |
| Out-of-Pocket Cap | ~$8,000 effective annual OOP Reached catastrophic phase, still paid 5% |
$2,000 hard annual cap Once you hit $2,000, you pay $0 for the rest of the year |
| Catastrophic Phase | 5% coinsurance with no ceiling For drugs costing $10K+/month, 5% still meant hundreds |
$0 cost sharing Full coverage after reaching $2,000 cap |
New: Medicare Prescription Payment Plan. Starting 2025, Part D enrollees can spread their out-of-pocket costs across monthly payments throughout the year instead of paying large sums at the pharmacy counter.
Who Benefits Most
The $2,000 cap has the greatest impact on beneficiaries taking high-cost specialty and brand-name drugs. These four categories see the largest savings.
Cancer Drugs
Biologics
MS Treatments
Anti-Rejection Drugs
Drug Impact Calculator
Estimate how much you could save under the new $2,000 annual cap. Enter your current monthly drug cost to see projected annual savings.
High-Impact Drugs
Drugs with the largest projected out-of-pocket savings under the IRA cap, based on Part D spending data.